Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Health

Set Alert for Digital Health

QUOTED. Jake Leach.

After receiving the nod from the FDA in July to let third-party developers integrate real-time continuous glucose monitoring data in their devices, Dexcom announced its first partnership is with Garmin. See what Jake Leach, Dexcom’s chief technology officer, said about it here.

Quoted Digital Health

Dexcom Announces CGM Real-Time Data Now Available On Garmin Wearables, Bike Computers

Dexcom is making CGM data available through consumer devices starting with Garmin’s smartwatches and bicycle computers.

Diabetic Care Digital Health

PDT Company Better Therapeutics Ready To Go Public With SPAC Deal

Better Therapeutics is developing prescription digital therapeutics for behavioral therapy to address the root causes of cardiometabolic disease.

Digital Health M & A

Pear Therapeutics Obtains First Medicaid Coverage For PDTs

Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.

Reimbursement Telehealth

Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.

Digital Health Artificial Intelligence

FDA Clears Withings' Smart Watch For Detecting AF and Measuring Blood Oxygen

The French company is promoting its ScanWatch as the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist.

Approvals Retail

What Does ‘Digital’ Mean For FDA’s Device Center?

Yes – the US FDA will adjust poor-fitting practices to accommodate digital devices. But the agency is not going to set aside product review, postmarket quality, and other basic requirements, former FDA device center compliance chief Steve Silverman argues in this opinion piece.

FDA Digital Health

QUOTED. Tej Tadi.

Digital therapeutics company MindMaze SA has closed a $125m investment round from AlbaCore Capital Group, one of Europe’s leading specialist investors focusing on the public and private corporate credit markets. CEO Tej Tadi explained what the firm hopes to do with the funds.

Quoted Financing
See All
UsernamePublicRestriction

Register